Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
5.79
+0.46 (8.63%)
Apr 29, 2026, 10:57 AM EDT - Market open
Cadrenal Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -13.24 | -10.65 | -8.36 | -7.32 |
| Depreciation & Amortization | 0.01 | 0 | 0 | 0 |
| Other Amortization | - | - | 0.01 | 0.07 |
| Stock-Based Compensation | 1.94 | 1.42 | 0.71 | 1.01 |
| Other Operating Activities | - | -0 | 3.96 | 4.26 |
| Change in Accounts Payable | -0.85 | 1.34 | -0.24 | 0.44 |
| Change in Other Net Operating Assets | -0.46 | 0.54 | 0.38 | 0.22 |
| Operating Cash Flow | -12.6 | -7.36 | -3.53 | -1.31 |
| Capital Expenditures | -0.01 | -0.01 | -0 | -0 |
| Investing Cash Flow | -0.01 | -0.01 | -0 | -0 |
| Total Debt Issued | - | - | - | 1.34 |
| Short-Term Debt Repaid | - | - | -0.25 | - |
| Total Debt Repaid | - | - | -0.25 | - |
| Net Debt Issued (Repaid) | - | - | -0.25 | 1.34 |
| Issuance of Common Stock | 7.16 | 5.14 | 12.15 | 0.01 |
| Other Financing Activities | -0.56 | 3.84 | - | - |
| Financing Cash Flow | 6.6 | 8.98 | 11.9 | 1.35 |
| Net Cash Flow | -6.01 | 1.62 | 8.37 | 0.04 |
| Free Cash Flow | -12.61 | -7.36 | -3.53 | -1.32 |
| Free Cash Flow Per Share | -6.32 | -6.04 | -3.93 | -2.50 |
| Levered Free Cash Flow | -7.78 | -3.56 | -3.92 | - |
| Unlevered Free Cash Flow | -7.78 | -3.56 | -3.92 | - |
| Change in Working Capital | -1.31 | 1.87 | 0.14 | 0.66 |
Source: S&P Capital IQ. Standard template.
Financial Sources.